Twist Bioscience TWST
NASDAQ TWST
$111.62 -4.73 (-4.07%)
At close: Nov 19, 2026 · 4:00 PM EST

Twist Bioscience (TWST) Gross Profit (2017 - 2026)

Updated

Twist Bioscience (TWST) reported Gross Profit of $67.25 million for fiscal Q4 2026 (quarter ended Sep 30, 2026), up 32.3% from $50.84 million a year earlier and up 7.7% from the prior quarter.

Analysis

Twist Bioscience (TWST) Gross Profit (2017 - 2026) Analysis & Trends

For FY2026 (ended Sep 30, 2026), Twist Bioscience posted Gross Profit of $240.8 million, up 26.1% from FY2025.

  • Gross Profit has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 36.0% (FY2021 to FY2026).
  • By fiscal year, Gross Profit came in at $191 million in FY2025 (+43.2%), $133.35 million in FY2024 (+48.6%), $89.73 million in FY2023 (+6.5%) and $84.24 million in FY2022 (+62.9%).
  • The fiscal Q4 2026 figure ranks as the highest quarterly Gross Profit in data going back to fiscal Q1 2018.
  • Year over year, Gross Profit has now increased in each of the last 12 quarters, with growth averaging 34.9% over the last eight quarters.
  • The high point for year-over-year Gross Profit in five years was fiscal Q3 2022 (growth of 78.5%); the low point was fiscal Q3 2023 (a decline of 12.9%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $62.45 million (Q3 2026), $57.12 million (Q2 2026) and $53.97 million (Q1 2026).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Twist Bioscience Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=TWST&period=max&api_key=YOUR_API_KEY